144 related articles for article (PubMed ID: 38227062)
21. Dual effect of RYGB on the entero-insular axis: How GLP-1 is enhanced by surgical duodenal exclusion.
Pérez-Arana GM; Díaz-Gómez A; Camacho-Ramírez A; Ribelles-García A; Almorza-Gomar D; Gracia-Romero M; Mateo-Gavira I; Castro-Santiago MJ; Casar-García J; Prada-Oliveira JA
Ann Anat; 2023 Aug; 249():152094. PubMed ID: 37011826
[TBL] [Abstract][Full Text] [Related]
22. Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery.
Svane MS; Bojsen-Møller KN; Nielsen S; Jørgensen NB; Dirksen C; Bendtsen F; Kristiansen VB; Hartmann B; Holst JJ; Madsbad S
Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E505-14. PubMed ID: 26786780
[TBL] [Abstract][Full Text] [Related]
23. Roux-en-Y gastric bypass promotes expression of PDX-1 and regeneration of beta-cells in Goto-Kakizaki rats.
Li Z; Zhang HY; Lv LX; Li DF; Dai JX; Sha O; Li WQ; Bai Y; Yuan L
World J Gastroenterol; 2010 May; 16(18):2244-51. PubMed ID: 20458761
[TBL] [Abstract][Full Text] [Related]
24. Down-Regulation of Renal Gluconeogenesis in Type II Diabetic Rats Following Roux-en-Y Gastric Bypass Surgery: A Potential Mechanism in Hypoglycemic Effect.
Wen Y; Lin N; Yan HT; Luo H; Chen GY; Cui JF; Shi L; Chen T; Wang T; Tang LJ
Obes Facts; 2015; 8(2):110-24. PubMed ID: 25832593
[TBL] [Abstract][Full Text] [Related]
25. Takeda G Protein-Coupled Receptor 5-Mechanistic Target of Rapamycin Complex 1 Signaling Contributes to the Increment of Glucagon-Like Peptide-1 Production after Roux-en-Y Gastric Bypass.
Zhai H; Li Z; Peng M; Huang Z; Qin T; Chen L; Li H; Zhang H; Zhang W; Xu G
EBioMedicine; 2018 Jun; 32():201-214. PubMed ID: 29859856
[TBL] [Abstract][Full Text] [Related]
26. Roux-en-Y gastric bypass versus calorie restriction: support for surgery per se as the direct contributor to altered responses of insulin and incretins to a mixed meal.
Berggren J; Lindqvist A; Hedenbro J; Groop L; Wierup N
Surg Obes Relat Dis; 2017 Feb; 13(2):234-242. PubMed ID: 27894746
[TBL] [Abstract][Full Text] [Related]
27. A surrogate of Roux-en-Y gastric bypass (the enterogastro anastomosis surgery) regulates multiple beta-cell pathways during resolution of diabetes in ob/ob mice.
Amouyal C; Castel J; Guay C; Lacombe A; Denom J; Migrenne-Li S; Rouault C; Marquet F; Georgiadou E; Stylianides T; Luquet S; Le Stunff H; Scharfmann R; Clément K; Rutter GA; Taboureau O; Magnan C; Regazzi R; Andreelli F
EBioMedicine; 2020 Aug; 58():102895. PubMed ID: 32739864
[TBL] [Abstract][Full Text] [Related]
28. Mechanism of Roux-en-Y gastric bypass treatment for type 2 diabetes in rats.
Yu H; Zheng X; Zhang Z
J Gastrointest Surg; 2013 Jun; 17(6):1073-83. PubMed ID: 23580087
[TBL] [Abstract][Full Text] [Related]
29. The Effect of Gastric Bypass with a Distal Gastric Pouch on Glucose Tolerance and Diabetes Remission in Type 2 Diabetes Sprague-Dawley Rat Model.
Dolo PR; Shao Y; Li C; Zhu X; Yao L; Wang H
Obes Surg; 2019 Jun; 29(6):1889-1900. PubMed ID: 30778846
[TBL] [Abstract][Full Text] [Related]
30. Impact of the hepatic branch of the vagus and Roux-en-Y gastric bypass on the hypoglycemic effect and glucagon-like peptide-1 in rats with type 2 diabetes mellitus.
Qiu NC; Zhang Q; Song X; Liu ME; Li XK; Shan CX; Qiu M
J Surg Res; 2014 Sep; 191(1):123-9. PubMed ID: 24768143
[TBL] [Abstract][Full Text] [Related]
31. Effects of Manipulating Circulating Bile Acid Concentrations on Postprandial GLP-1 Secretion and Glucose Metabolism After Roux-en-Y Gastric Bypass.
Jonsson I; Bojsen-Møller KN; Kristiansen VB; Veedfald S; Wewer Albrechtsen NJ; Clausen TR; Kuhre RE; Rehfeld JF; Holst JJ; Madsbad S; Svane MS
Front Endocrinol (Lausanne); 2021; 12():681116. PubMed ID: 34084153
[TBL] [Abstract][Full Text] [Related]
32. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
Jørgensen NB; Jacobsen SH; Dirksen C; Bojsen-Møller KN; Naver L; Hvolris L; Clausen TR; Wulff BS; Worm D; Lindqvist Hansen D; Madsbad S; Holst JJ
Am J Physiol Endocrinol Metab; 2012 Jul; 303(1):E122-31. PubMed ID: 22535748
[TBL] [Abstract][Full Text] [Related]
33. Contribution of endogenous glucagon-like peptide-1 to changes in glucose metabolism and islet function in people with type 2 diabetes four weeks after Roux-en-Y gastric bypass (RYGB).
Shah M; Laurenti MC; Dalla Man C; Ma J; Cobelli C; Rizza RA; Vella A
Metabolism; 2019 Apr; 93():10-17. PubMed ID: 30586575
[TBL] [Abstract][Full Text] [Related]
34. Preserved Insulin Secretory Capacity and Weight Loss Are the Predominant Predictors of Glycemic Control in Patients With Type 2 Diabetes Randomized to Roux-en-Y Gastric Bypass.
Nguyen KT; Billington CJ; Vella A; Wang Q; Ahmed L; Bantle JP; Bessler M; Connett JE; Inabnet WB; Thomas A; Ikramuddin S; Korner J
Diabetes; 2015 Sep; 64(9):3104-10. PubMed ID: 25901097
[TBL] [Abstract][Full Text] [Related]
35. The Effect of Standard Versus Longer Intestinal Bypass on GLP-1 Regulation and Glucose Metabolism in Patients With Type 2 Diabetes Undergoing Roux-en-Y Gastric Bypass: The Long-Limb Study.
Miras AD; Kamocka A; Pérez-Pevida B; Purkayastha S; Moorthy K; Patel A; Chahal H; Frost G; Bassett P; Castagnetto-Gissey L; Coppin L; Jackson N; Umpleby AM; Bloom SR; Tan T; Ahmed AR; Rubino F
Diabetes Care; 2021 May; 44(5):1082-1090. PubMed ID: 33158945
[TBL] [Abstract][Full Text] [Related]
36. Roux-en-Y gastric bypass alters intestinal glucose transport in the obese Zucker rat.
Meng Q; Culnan DM; Ahmed T; Sun M; Cooney RN
Front Endocrinol (Lausanne); 2022; 13():901984. PubMed ID: 36034439
[TBL] [Abstract][Full Text] [Related]
37. Glucagon-like peptide-1 effect on β-cell function varies according to diabetes remission status after Roux-en-Y gastric bypass.
Shah A; Prasad M; Mark V; Holst JJ; Laferrère B
Diabetes Obes Metab; 2022 Nov; 24(11):2081-2089. PubMed ID: 35676799
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of RYGB surgery and best medical treatment for obesity-diabetes on intestinal and islet adaptations in obese-diabetic ZDSD rats.
Sridhar A; Khan D; Abdelaal M; Elliott JA; Naughton V; Flatt PR; Le Roux CW; Docherty NG; Moffett CR
PLoS One; 2022; 17(9):e0274788. PubMed ID: 36137097
[TBL] [Abstract][Full Text] [Related]
39. Roux-en-Y gastric bypass compared with equivalent diet restriction: Mechanistic insights into diabetes remission.
Pop LM; Mari A; Zhao TJ; Mitchell L; Burgess S; Li X; Adams-Huet B; Lingvay I
Diabetes Obes Metab; 2018 Jul; 20(7):1710-1721. PubMed ID: 29532631
[TBL] [Abstract][Full Text] [Related]
40. Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass.
Dirksen C; Bojsen-Møller KN; Jørgensen NB; Jacobsen SH; Kristiansen VB; Naver LS; Hansen DL; Worm D; Holst JJ; Madsbad S
Diabetologia; 2013 Dec; 56(12):2679-87. PubMed ID: 24048673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
